Physician

Marcus L Allen, MD

According to 2025 Medicare claims, Marcus Allen, MD (NPI: 1164481297) practices ophthalmology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is RETINA INSTITUTE OF TEXAS PA (NPI: 1326097460; TIN: 751453852) and primary practice location at 76210-0102.

Allen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,239 traditional Medicare patients, billed 35,536 HCPCS/CPT codes, and received $2,965,810 in Medicare payments. The top billing code was J2778 (Injection, ranibizumab, 0.1 mg). Part D data shows 1,020 prescription claims across 305 beneficiaries totaling $55,148 in drug costs, led by Ketorolac Tromethamine (Ketorolac Tromethamine). Open Payments data shows 2 records totaling $40. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,064,677 to $2,965,810. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.2M2015 Medicare payment: $1,064,677 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,126,466 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,074,586 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,160,550 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,208,325 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,235,432 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,229,086 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,065,716 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,674,296 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,965,810 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,52213,721$1,064,677
20161,53215,603$1,126,466
20171,54714,368$1,074,586
20181,51616,025$1,160,550
20191,49718,398$2,208,325
20201,27920,119$3,235,432
20211,26220,791$3,229,086
20221,24120,332$3,065,716
20231,28821,814$2,674,296
20241,23935,536$2,965,810

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$50K$99K2015 Drug cost: $72,257 (USD; Tot_Drug_Cst)2016 Drug cost: $69,251 (USD; Tot_Drug_Cst)2017 Drug cost: $74,239 (USD; Tot_Drug_Cst)2018 Drug cost: $76,176 (USD; Tot_Drug_Cst)2019 Drug cost: $75,095 (USD; Tot_Drug_Cst)2020 Drug cost: $87,030 (USD; Tot_Drug_Cst)2021 Drug cost: $86,056 (USD; Tot_Drug_Cst)2022 Drug cost: $99,276 (USD; Tot_Drug_Cst)2023 Drug cost: $66,527 (USD; Tot_Drug_Cst)2024 Drug cost: $55,148 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015222780$72,257
2016256820$69,251
2017276905$74,239
2018284954$76,176
2019282926$75,095
2020262981$87,030
20212591,042$86,056
20222791,000$99,276
20232961,064$66,527
20243051,020$55,148

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J2778Injection, ranibizumab, 0.1 mg35211,010$125
67028Injection of drug into eye4362,488$91
92014Established patient complete exam of visual system8861,013$84
92012Established patient problem focused exam of visual system6611,696$61
92134Imaging of retina1,1343,193$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Ketorolac TromethamineKetorolac Tromethamine19311,139$5,729
Prednisolone AcetatePrednisolone Acetate1084,399$4,455
Brimonidine TartrateBrimonidine Tartrate161,175$3,677
BrinzolamideBrinzolamide171,090$3,320
Diclofenac SodiumDiclofenac Sodium1899,531$2,378

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$40ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marcus L. Allen, MD?

Tedicare shows public-source Medicare data for Marcus L. Allen, MD (NPI 1164481297), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marcus L. Allen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marcus L. Allen, MD?

Marcus L. Allen, MD is linked to RETINA INSTITUTE OF TEXAS PA (billing NPI 1326097460) in the available physician profile data.

Does Marcus L. Allen, MD have Open Payments data?

Marcus L. Allen, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.